TTToshihiro Takami

Toshihiro Takami

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Toshihiro Takami has a total of 235 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Transporter‐Associated Therapeutic Efficacy of an SMVT ‐Targeted Boron Carrier in Boron Neutron Capture Therapy

    byĀ Kenichiro Eza, Kohei Tsujino, Rina Shidoh‐Kazuki, Yoshiki Fujikawa, Hideki Kashiwagi, Gen Futamura, Ryo Hiramatsu, Toshihiro Takami, Masahiko Wanibuchi, Naonori Hu, et al.

    Boron neutron capture therapy (BNCT) requires selective delivery of boron compounds to tumor cells to achieve therapeutic efficacy. In this study, a BNCT strategy centered on the sodium‐dependent multivitamin transporter (SMVT)‐targeted biotin‐conjugated boron compound, BBCIP, was evaluated, with selective incorporation of p‐boronophenylalanine (BPA) according to tumor transporter characteristics. To examine transporter‐dependent effects, the CRL1666 metastatic brain tumor model in rats was compared with an F98 glioma model, which exhibits distinct transporter expression profiles. The F98 model is characterized by dominant L‐type amino acid transporter 1 (LAT1) expression and low SMVT levels, whereas the CRL1666 model shows relatively high SMVT expression. BBCIP demonstrated stable and quantifiable intratumoral boron pharmacokinetics in both models. In BNCT experiments, BBCIP alone showed limited therapeutic efficacy in the LAT1‐dominant F98 model (median survival, 29 vs. 23 days in controls), whereas survival was further improved with the addition of BPA. In contrast, in the SMVT‐high CRL1666 model, BBCIP‐based BNCT significantly prolonged survival (30 vs. 15.5 days in controls), with only modest additional benefit from BPA. These findings indicate that the therapeutic contribution of BBCIP‐based BNCT depends on tumor transporter expression and that BPA may be advantageous in tumors with low SMVT expression. Rather than relying on a single boron carrier, these findings support a biology‐driven strategy in which boron agents are selected and combined according to tumor‐specific characteristics.

  • Correction: Boron neutron capture therapy prolongs survival in a rat model of multifocal brain metastases

    byĀ Rina Shidoh-Kazuki, Yoshiki Fujikawa, Shinji Kawabata, Kohei Tsujino, Hironori Yamada, Fugen Takagi, Hideki Kashiwagi, Ryo Hiramatsu, Naosuke Nonoguchi, Toshihiro Takami, et al.

  • Boron neutron capture therapy prolongs survival in a rat model of multifocal brain metastases

    byĀ Rina Shidoh-Kazuki, Yoshiki Fujikawa, Shinji Kawabata, Kohei Tsujino, Hironori Yamada, Fugen Takagi, Hideki Kashiwagi, Ryo Hiramatsu, Naosuke Nonoguchi, Toshihiro Takami, et al.

    Purpose Boron neutron capture therapy (BNCT) is a tumor-selective radiation modality that delivers high–linear energy transfer alpha and Lithium-7 particles to boron-containing cells following neutron irradiation. While both preclinical and clinical investigations of BNCT for intracranial tumors have primarily focused on solitary lesions, brain metastases frequently present as multifocal disease in clinical practice. The therapeutic efficacy of BNCT in this setting remains insufficiently explored. Methods We evaluated the therapeutic efficacy of BNCT in rat models of solitary and multiple brain metastases established using a syngeneic breast cancer cell line. Boronophenylalanine was administered intravenously prior to neutron irradiation. Survival outcomes were compared among untreated controls, neutron irradiation alone, and BNCT groups. Boron biodistribution was analyzed to determine optimal irradiation timing, and treatment safety was assessed by longitudinal monitoring of body weight. Results BNCT significantly prolonged post-irradiation survival compared with neutron irradiation alone and untreated controls in both solitary and multiple tumor models. Notably, a substantial survival benefit was maintained even in the multiple brain metastasis model, despite the presence of spatially distributed intracranial tumor burden. Biodistribution analysis demonstrated preferential boron accumulation in tumor tissue relative to normal brain. Body weight monitoring indicated no significant treatment-related toxicity. Conclusion BNCT demonstrated therapeutic efficacy and feasibility in a preclinical model of multiple brain metastases, providing a survival benefit without excessive toxicity. These findings support further investigation of BNCT as a potential treatment strategy for multifocal intracranial disease.

  • Open Access

    Accessory Nerve Schwannomas Presenting with Hypoglossal Nerve Palsy: A Narrative Review with an Illustrative Case

    byĀ Gen Futamura, Ryokichi Yagi, Masao Fukumura, Moeko Tani, Hideki Kashiwagi, Yuichiro Tsuji, Ryo Hiramatu, Masahiro Kameda, Naosuke Nonoguchi, Motomasa Furuse, et al.

    Background: Intracranial accessory nerve schwannomas involving the jugular foramen are rare tumors with heterogeneous clinical presentations. Although lower cranial nerve dysfunction is common, hypoglossal nerve palsy is uncommon and may obscure identification of the nerve of origin. Methods : A narrative review of the literature was conducted to identify reported cases from 1961 to December 2025. Clinical manifestations were categorized as initial and preoperative symptoms, and their temporal evolution was analyzed according to tumor location. Imaging findings, surgical management, and neurological outcomes were reviewed. An illustrative case with hypoglossal nerve palsy was included. Results: A total of 58 cases, including the present case, were identified. According to the Julow classification, 38 tumors were intracisternal and 20 were intrajugular. Intracisternal tumors predominantly caused posterior fossa compression symptoms, whereas intrajugular tumors more frequently showed lower cranial nerve dysfunction. Hypoglossal nerve palsy was observed in seven cases, including three as the initial symptom, and occurred mainly in intrajugular tumors. Imaging commonly demonstrated jugular foramen enlargement and, in selected cases, continuity with enlargement of the extracranial hypoglossal canal. Surgical treatment was associated with improvement or stabilization of hypoglossal nerve function in all reported cases. Conclusions: Accessory nerve schwannomas may occasionally present with hypoglossal nerve palsy, most likely due to secondary compression. Careful assessment of symptom progression and skull base imaging may improve preoperative diagnosis and surgical planning.

  • Open Access

    Photodynamic therapy for recurrent spinal diffuse midline glioma with a modest extension of overall survival: illustrative case

    byĀ Masao Fukumura, Moeko Tani, Rina Kazuki, Hideki Kashiwagi, Takuya Kosaka, Shigeru Kawabata, Naosuke Nonoguchi, Toshiki Endo, Toshihiro Takami, Masahiko Wanibuchi

    BACKGROUND: Diffuse midline glioma (DMG), a highly malignant CNS tumor, is classified as a World Health Organization grade 4 tumor. Its overall survival prognosis, even after standard treatment, is typically extremely poor. Photodynamic therapy (PDT) represents an innovative treatment modality with promising results for intracranial malignant gliomas. However, its use for spinal malignant gliomas has not yet been explored, despite their pathological similarity to intracranial malignant gliomas. OBSERVATIONS: The present case of a 28-year-old female patient with recurrent spinal DMG represents the first documented report concerning the effects of PDT on spinal malignant gliomas, with the pathological postmortem findings. Despite the successful application of PDT to the resection cavity of the spinal DMG, cervical spinal cord edema developed soon after surgery. The blood flow to the spinal cord parenchyma was thought to be altered but reversible. The patient’s overall survival was 21 months after the initial surgery. LESSONS: This case highlights the potential of PDT as a feasible and promising adjunctive treatment for spinal malignant gliomas. The observed clinical course and pathological findings may provide valuable insights for future research and therapeutic development. https://thejns.org/doi/10.3171/CASE25751

  • Open Access

    Pathogenesis of Spinal Subdural Hematoma Based on Histopathological Findings: A Case Report

    byĀ Yoshiki Fujikawa, Takahiro Fujishiro, Hideki Tanabe, Toshihiro Takami, Masahiko Wanibuchi

    Spinal subdural hematoma is a rare condition whereas intracranial chronic subdural hematoma is well-recognized and documented in clinical settings. Despite various theories that have been proposed, the exact pathogenesis of spinal subdural hematoma remains to be elucidated. Herein, we report a rare case of spinal subdural hematoma with a co-existing intracranial chronic subdural hematoma and deduce its etiology using histopathological findings. A 76-year-old Japanese man with slight hemiparesis due to intracranial chronic subdural hematoma underwent burr hole surgery with successful drainage of the hematoma. The patient could not walk unassisted after the surgery. Spinal magnetic resonance imaging was performed, revealing a subdural hematoma extending from the T11 to S2 levels. The patient subsequently underwent the evacuation of spinal subdural hematoma 12 days after initial surgery. Intraoperatively, we identified a dark liquefied hematoma with capsule formation. Histological examination of the resected capsule revealed loose fibrovascular tissues comprising capillaries, collagen fibers, a small number of macrophages, and hemosiderin deposits. These findings were very similar to the pathology of intracranial chronic subdural hematoma so the pathogenesis of spinal subdural hematoma in this case was considered identical to that of subacute or chronic subdural hematoma. The patient was transferred to a rehabilitation hospital, and 4 months after the lumbar surgery, no recurrence was observed in the magnetic resonance imaging examination. Subacute or chronic spinal subdural hematoma may result from various pathogeneses that clinicians should consider for correct diagnosis and appropriate management. Our case provides important insights into the pathogenesis of subacute or chronic spinal subdural hematoma.


  • Paraspinal muscular fat infiltration was associated with the development of adjacent segmental disease after microsurgical decompression without fusion for single-level lumbar spinal stenosis

    byĀ Naokado Ikeda, Kunio Yokoyama, Yutaka Ito, Hidekazu Tanaka, Makoto Yamada, Akira Sugie, Toshihiro Takami, Masahiko Wanibuchi, Masahiro Kawanishi

    Purpose This study investigated the association between preoperative radiological parameters, including paraspinal muscle sarcopenia, and the development of adjacent segmental disease (ASD) after microsurgical decompression (MSD) without fusion for lumbar spinal stenosis (LSS). Methods Patients who underwent MSD for single-level LSS and were followed-up for ≄ 5 years at our institution were retrospectively reviewed. Paraspinal muscle volumes were calculated as the total cross-sectional area of each muscle divided by the L3 vertebral body area. The paraspinal muscle quality (percentage of psoas fat infiltration [PMFI%] and percentage of multifidus muscle fat infiltration [MFMFI%]) was calculated as the hyperintensity area divided by the cross-sectional area of each muscle in the preoperative L3 vertebral body level on axial T2-weighted magnetic resonance image. The preoperative radiological factors including the abovementioned parameters, which can affect the development of ASD requiring surgery after MSD for LSS, were statistically analyzed. Results In total, 97 patients with a mean age of 69.1 ± 7.99 years and a median follow-up period of 7.00 (5.00–9.00) years were included in the analysis. The preoperative radiographical factors, including paraspinal muscle volumes, did not influence the development of postoperative ASD. However, the preoperative PMFI% and MFMFI% were significantly related to postoperative ASD. Based on a multivariate analysis, MFMFI% was independently associated with the development of postoperative ASD. Conclusion A higher paraspinal muscular fat infiltration is an important predictive factor of ASD after single-level MSD for LSS and after fusion surgery. Therefore, spine-specific sarcopenia can have a significant effect on surgical prognosis.


  • Open Access

    Posterolateral Sulcus Approach for Intramedullary Hemorrhage Associated With Cavernous Malformation of High Cervical Spine: Operative Technique and Outcomes

    byĀ Yoshiki Fujikawa, Hideki Kashiwagi, Masao Fukumura, Ryokichi Yagi, Ryo Hiramatsu, Masahiro Kameda, Naosuke Nonoguchi, Motomasa Furuse, Shinji Kawabata, Toshihiro Takami, et al.

    Objective: Intramedullary hemorrhage (IH) associated with cavernous malformation (CM) of the high cervical spine remains a significant challenge for neurosurgeons. This study aimed to evaluate the efficacy and safety of the posterolateral sulcus (PLS) approach in managing these complex cases.Methods: This single-center retrospective study included 58 cases of spinal intramedullary tumors treated surgically over the past 4 years. The PLS approach on the side of the IH was applied for the removal of CM. Neurological function was assessed using the modified McCormick functional scale (MMCS) before surgery, one week after surgery, and at the most recent follow-up.Results: Six patients with IH associated with CM above the C3 level were identified from the database. The mean age was 31.2 years, and 4 of the 6 patients were female. Symptom duration prior to surgery ranged from 0 to 48 months. Total removal of the CM was achieved in all 6 cases without any serious adverse events including respiratory complications. The average follow-up duration was 21.7 months. The mean MMCS score was 3.0 before surgery, maintained at 2.5 in the early postoperative period, and improved further to 2.2 at the most recent follow-up. One patient of ventral-type CM experienced recurrent hemorrhage at the same level 30 months after the initial surgery. This patient subsequently underwent a second surgery using the anterolateral sulcus approach, which was well tolerated.Conclusion: The PLS approach enables safe removal of CM even in the high cervical spine. However, ventral-type CMs remain a major surgical concern.


  • Open Access

    Intelligent Ultrasonic Aspirator Controlled by Fiber-Optic Neoplasm Sensor Detecting 5-Aminolevulinic Acid-Derived Porphyrin Fluorescence

    byĀ Yoshinaga Kajimoto, Hidefumi Ota, Masahiro Kameda, Naosuke Nonoguchi, Motomasa Furuse, Shinji Kawabata, Toshihiko Kuroiwa, Toshihiro Takami, Masahiko Wanibuchi

    The development of an intelligent ultrasonic aspirator controlled by a fiber-optic neoplasm sensor that detects 5-aminolevulinic acid-derived porphyrin fluorescence presents a significant advancement in glioma surgery. By leveraging the fluorescence phenomenon associated with 5-aminolevulinic acid in malignant neoplasms, this device integrates an excitation laser and a high-sensitivity photodiode into the tip of an ultrasonic aspirator handpiece. This setup allows for real-time tumor fluorescence detection, which in turn modulates the aspirator’s power based on fluorescence intensity. Preliminary testing demonstrated high sensitivity, with the device capable of differentiating between weak, strong, and no fluorescence. The sensor sensitivity was comparable to human visual perception, enabling effective tumor differentiation. Tumors with strong fluorescence were effectively crushed, while the aspirator ceased operation in non-fluorescent areas, enabling precise tissue resection. Furthermore, the device functioned efficiently in bright surgical environments and was designed to maintain a clean sensor tip through constant saline irrigation. The system was successfully applied in a surgical case of recurrent glioblastoma, selectively removing tumor tissue while preserving surrounding brain tissue. This innovative approach shows promise for safer, more efficient glioma surgeries and may pave the way for sensor-based robotic surgical systems integrated with navigation technologies.